---
id: 209
title: Acute Cholangitis
category: clinical_syndromes
subcategory: gastrointestinal
tags: [cholangitis, Charcot-triad, Reynolds-pentad, ERCP, biliary-obstruction, pip-tazo]
difficulty: high
---

## Question

How is acute cholangitis managed? Use **"Urgent ERCP (<24h if Severe) + Pip-Tazo/Carbapenem × 7d, Charcot Triad (Fever, RUQ Pain, Jaundice)"** framework.

## Answer

### **Clinical Presentation:**

**Charcot Triad (50-70%):**
- **Fever/chills** (>90%)
- **Right upper quadrant (RUQ) pain** (70%)
- **Jaundice** (60%)

**Reynolds Pentad (Severe, 5-10%):**
- **Charcot triad + hypotension + altered mental status**
- **Suggests suppurative cholangitis** (pus in biliary tree)

### **Diagnosis:**

**Tokyo Guidelines 2018 (TG18):**

**Criterion A (Systemic Inflammation):**
- **Fever ≥38°C** and/or **chills**
- **Laboratory:** WBC <4,000 or >10,000, CRP ≥1 mg/dL

**Criterion B (Cholestasis):**
- **Jaundice** (total bilirubin ≥2 mg/dL)
- **↑Alkaline phosphatase, GGT** (>1.5× ULN)

**Criterion C (Imaging):**
- **Biliary dilation** (CBD >6 mm, or >10 mm if post-cholecystectomy)
- **Evidence of obstruction** (stone, stricture, stent occlusion)

**Diagnosis:** **A + B + C = Definite cholangitis**

### **Severity Grading (Tokyo Guidelines):**

**Grade I (Mild):**
- **Meets diagnostic criteria**
- **No organ dysfunction**

**Grade II (Moderate):**
- **≥2 of:**
  - WBC >12,000 or <4,000
  - Fever ≥39°C
  - Age ≥75 years
  - Bilirubin ≥5 mg/dL
  - Albumin <2.5 g/dL

**Grade III (Severe):**
- **≥1 organ dysfunction:**
  - Hypotension (SBP <90, requiring vasopressors)
  - Altered mental status
  - Respiratory failure (PaO₂/FiO₂ <300)
  - Acute kidney injury (Cr >2 mg/dL)
  - Coagulopathy (INR >1.5)
  - Thrombocytopenia (<100,000)

### **Microbiology:**

**Common Pathogens:**
- ***E. coli*** (most common, 30-40%)
- ***Klebsiella pneumoniae*** (15-25%)
- **Other Gram-negatives:** *Enterobacter*, *Citrobacter*
- ***Enterococcus* species** (15-25%)
- **Anaerobes:** *Bacteroides*, *Clostridium* (if biliary-enteric anastomosis)

**Risk for MDROs (ESBL, *Pseudomonas*):**
- **Recent antibiotics**
- **Prior biliary instrumentation** (ERCP, stent)
- **Healthcare-associated**

### **Treatment:**

**1. Biliary Drainage (Definitive Therapy):**

**Timing:**
- **Grade I (Mild):** ERCP within **24-72 hours**
- **Grade II (Moderate):** ERCP within **24 hours**
- **Grade III (Severe):** **Urgent ERCP <24 hours** OR emergent biliary decompression (percutaneous transhepatic biliary drainage if ERCP not feasible)

**Methods:**
- **ERCP with sphincterotomy + stone extraction** (preferred)
- **Percutaneous transhepatic biliary drainage (PTBD)** (if ERCP fails or not feasible)
- **Endoscopic ultrasound-guided biliary drainage (EUS-BD)** (alternative if ERCP fails)

**2. Empiric Antibiotics:**

**Community-Acquired, Mild-Moderate:**
- **Piperacillin-tazobactam 3.375-4.5g IV q6-8h**
- **Ceftriaxone 1-2g IV daily + metronidazole 500mg IV q8h** (if biliary-enteric anastomosis)
- **Ciprofloxacin 400mg IV q12h + metronidazole** (alternative)

**Severe OR Healthcare-Associated:**
- **Meropenem 1g IV q8h** OR **imipenem 500mg IV q6h**
- **Piperacillin-tazobactam 4.5g IV q6h** (extended infusion)

**If MRSA Risk (Biliary Stent, Recent Healthcare):**
- **Add vancomycin 15-20 mg/kg IV q8-12h**

**Duration:**
- **4-7 days** (if adequate drainage)
- **7-10 days** (if bacteremia, delayed drainage)
- **Do NOT prolong if adequate drainage** achieved

### **Supportive Care:**

**Fluid Resuscitation:**
- **Aggressive IV fluids** (often hypovolemic from sepsis)

**Vasopressors:**
- **Norepinephrine** (if hypotension despite fluids)

**ICU Monitoring:**
- **If Grade III (severe)**

### **Blood Cultures:**

- **Positive in 20-70%** (higher with severe disease)
- **Obtain before antibiotics**

### **Complications:**

**Acute:**
- **Septic shock** (10-30% if severe)
- **Acute kidney injury**
- **Liver abscess** (5-10%)

**Chronic:**
- **Recurrent cholangitis** (if stent, stricture)
- **Secondary biliary cirrhosis**

### **Prognosis:**

**Mortality:**
- **Grade I (Mild):** <2%
- **Grade II (Moderate):** 5-10%
- **Grade III (Severe):** 10-30%

## Key Points

### **Charcot Triad:**
- **Fever + RUQ pain + jaundice** (classic, 50-70%)
- **Reynolds pentad:** + hypotension + AMS (severe, 5-10%)

### **Urgent Biliary Drainage = Definitive:**
- **Grade I:** ERCP within 24-72h
- **Grade II-III:** **Urgent ERCP <24h** (or emergent decompression)

### **Empiric = Pip-Tazo or Carbapenem:**
- **Mild-moderate:** Pip-tazo OR ceftriaxone + metronidazole
- **Severe:** Meropenem OR high-dose pip-tazo

### **Duration: 4-7 Days:**
- **Adequate if drainage successful**
- **Extend to 7-10 days** if bacteremia, delayed drainage

### **Common Pathogen: *E. coli*:**
- **Polymicrobial common** (*E. coli* + *Enterococcus*)
- **ESBL risk** if recent antibiotics, prior instrumentation

### **Clinical Pearls:**
- **Charcot triad** (fever, RUQ pain, jaundice) + **urgent ERCP <24h** if severe
- **Pip-tazo × 4-7 days** (if adequate drainage)
- **Bacteremia common** (20-70%), obtain blood cultures
- **Tokyo Guidelines:** Grade III = urgent drainage <24h
- ***E. coli*** most common pathogen (30-40%)

## Sources

- [Tokyo Guidelines: Acute Cholangitis 2024]
- [JAMA: Management of Acute Cholangitis 2024]

## Media

N/A
